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Our 1993 paper entitled "The C. elegans Cell Death Gene 
ced-3 Encodes a Protein Similar to Mammalian Interleu- 
kin-l-13-Converting Enzyme" (Yuan et al., 1993) an- 
nounced the discovery of a molecular mechanism for 
programmed cell death in the nematode Caenorhabditis 
elegans and led us to suggest that this mechanism is 
likely conserved in mammals. Our first glimpse of the 
impact this paper would have on the fields of biology 
and medicine came the day this paper was published: 
that day a number of pharmaceutical companies con- 
tacted one of us (H.R.H.) to ask how this finding could 
help them discover drugs. Nonetheless, its subsequent 
effect on the field of mammalian apoptosis was beyond 
our imagination at the time. 
In the past decade, the field of apoptosis has become 
enormous, with more than 10,000 published papers di- 
rected toward an understanding of CED-3-1ike prote- 
ases, now known as caspases, and more than 70,000 
papers toward the understanding of apoptosis in gen- 
eral. Many of these latter papers use caspase activation 
as their primary marker for the process of apoptosis. 
The Yuan et al. (1993) paper, coupled with the compan- 
ion paper by Miura et al. (1993), which showed that 
CED-3 expressed in mammalian cells could induce 
those cells to undergo apoptosis, not only provided the 
first insight concerning the molecular mechanisms of 
apoptosis but also established one of the first two (also 
see Vaux et al., 1992) direct links between the genetic 
analysis of programmed cell death in C. elegans and 
the field of mammalian apoptosis. 
That ced-3, a gene required for programmed cell 
death in C. elegans, encodes a protein resembling mam- 
malian interleukin-l~ converting enzyme, a cysteine 
protease now termed caspase-1, strongly suggested 
that the CED-3 protein functions as a cysteine protease 
in regulating programmed cell death in worms, ced-3 
had been identified by Hilary Ellis in a genetic screen 
for mutations that suppress the presence of persistent 
cell corpses caused by a mutation in ced-1, a gene 
required for the engulfment of dying cells (Ellis and Hor- 
vitz, 1986). In wild-type worms, cells undergoing pro- 
grammed cell death are efficiently recognized, engulfed, 
and degraded by neighboring cells. The engulfment pro- 
cess is now known to be regulated by at least seven 
genes, which encode components of two parallel and 
partially redundant signal transduction pathways (e.g., 
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Reddien and Horvitz, 2000; Zhou et al., 2001). ced-1, the 
first engulfment gene to be identified, was discovered by 
Ed Hedgecock in a genetic screen for morphological 
mutants using Nomarski microscopy (Hedgecock et al., 
1983). The engulfment defect of ced- 1 delays the degra- 
dation of dead cells and provided a genetic background 
that allowed the ready visualization of accumulated un- 
engulfed cell corpses. 
The first ced-3 mutation was isolated because it elimi- 
nated the persistent cell corpses observed in ced-1 ani- 
mals. Further analysis revealed these corpses were ab- 
sent because without ced-3 function programmed cell 
death was not initiated. This observation demonstrated 
that ced-3 acts as a killer gene in programmed cell 
death. Although the ability of inhibitors of protein and 
RNA synthesis to block metamorphic ell death in tad- 
poles and insects and to block certain cell deaths in 
culture had led to suggestions that cell death required 
gene activity (e.g., Lockshin, 1969; Tata, 1966), it was 
the discovery of ced-3 (and of the second C. elegans 
killer gene ced-4; Ellis and Horvitz, 1986) that directly 
demonstrated the existence of genes that act in the 
process of programmed cell death. 
How ced-3 might regulate programmed cell death was 
a frequent subject of debate in our laboratory at the 
time. Since an increase in levels of the hormone 20- 
hydroxyecdysone had been shown to be critical in de- 
termining the onset of metamorphic ell death in insects 
(Schwartz and Truman, 1983), it seemed possible that 
ced-3 could encode a gene regulating the production 
and/or secretion of a similar hormone in worms. How- 
ever, our genetic mosaic analyses of ced-3 and ced-4 
indicated that both of these genes act cell autonomously 
in dying cells to control programmed cell death (Yuan 
and Horvitz, 1990). Thus, neither ced-3 nor ced-4 en- 
codes a factor secreted to initiate programmed cell 
death, although it remained possible that one or both 
of these genes control a pathway that acts in cells that 
are to die in response to a secreted factor from other 
cells. 
Because we regarded programmed cell death essen- 
tially as a cell fate, much like differentiating into a neuron 
or an intestinal cell, we also considered the possibility 
that ced-3 acts like other cell-fate determining enes, 
by controlling, for example, the transcription of genes 
that promote a cell-autonomous death process. The dis- 
covery that ced-3 encodes a cysteine protease indi- 
cated that it functions in a completely unanticipated 
way. The ability of ced-3 to induce the death of mamma- 
lian cells in a cell-autonomous fashion (Miura et al., 1993) 
suggested that both CED-3 and mammalian caspases 
cause cells to die by a mechanism more direct than that 
of a hormone or a transcription factor. 
The Yuan et ai. (1993) paper bridged two lines of pre- 
viously unrelated studies of invertebrates and verte- 
brates. In the late 1980s, the critical roles of IL-I~ in 
mediating inflammatory responses made the inhibition 
of IL-1 signaling an intensely sought after therapeutic 
goal with a number of pharmaceutical and biotechnol- 
ogy companies attempting to purify the protease that 
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processed the proform of IL-113 into the active cytokine. 
These efforts led to the identification of a cysteine prote- 
ase, now called caspase-1, as the processing enzyme 
for pro-lL-l[3 (Cerretti et al., 1992; Thomberry et al., 
1992). Structural and functional information about cas- 
pase-1 was crucial in defining its similarity with CED-3, 
as the sequence identity between the two is only 29%, 
barely significant statistically. The knowledge that the 
active center of caspase-1 contains the amino acid se- 
quence QACRG, which encompasses the active-site 
cysteine and is also present in CED-3, made the similar- 
ity convincing. Suddenly, the efforts in the pharmaceuti- 
cal industry focused on the IL-113 processing enzyme 
and inflammatory disease became connected to the 
biology of programmed cell death. 
In the Yuan et al. (1993) paper, we predicted that 
mammalian caspase-1, or other mammalian members of 
the CED-3/caspase-1 family, might regulate apoptosis. 
This idea, which has since been confirmed by a large 
body of data (e.g., reviewed by Friedlander and Yuan, 
1998), was surprising at the time to those studying IL- 
113 and its processing enzyme. There are still debates 
about whether or not caspase-1 and the mammalian 
caspases most closely related to caspase-1 are special- 
ized for inflammatory processes or also function in apo- 
ptosis. For example, the lack of gross developmental 
defects in caspase-l-deficient mice (Kuida et al., 1995; 
Li et al., 1995) has been interpreted to indicate that 
caspase-1 is not directly involved in regulating apopto- 
sis. Nevertheless, caspase-1 is activated and IL-113 lev- 
els are elevated in a variety of animal models of human 
diseases associated with cell deaths, including ischemic 
brain injury, multiple sclerosis and Huntington's Disease 
(Hara et al., 1997; Hisahara et al., 2001; Ona et al., 1999). 
Also, transgenic mice expressing an active-site muta- 
tion in caspase-1 and caspase-1 -deficient mice are par- 
tially protected from neuronal cell death induced by 
ischemic brain injury (Friedlander et al., 1997; Schielke 
et al., 1998), suggesting the involvement of caspase-1 
in acute neuronal cell death. Thus, caspase-1 may well 
be involved in regulating apoptosis under certain patho- 
logical conditions. Nonetheless, even in cases in which 
a deficiency in caspase-1 results in a reduction of apo- 
ptosis, such as in mouse models of ischemic brain injury, 
it remains possible that caspase-1 acts cell autono- 
mously as well as by regulating a secreted cytokine(s), 
such as IL-113. 
In any event, there is now an established connection 
between inflammation and apoptosis: inflammation is 
generally associated with apoptosis, and apoptosis may 
promote inflammation (although apoptosis is not neces- 
sarily accompanied by inflammation). This connection 
is exemplified by the dual role of murine caspase-11, 
which regulates inflammation by mediating the activa- 
tion of caspase-1 and apoptosis by directly activating 
caspase-3 (Kang et al., 2000). Such findings suggest 
that caspase inhibition targeting both inflammation and 
apoptosis may be a successful strategy for the treat- 
ment of human inflammatory diseases. 
One aspect of mammalian apoptosis that could not 
be directly predicted by the Yuan et al. (1993) paper is 
the number of and interactions among caspases present 
in mammals. Our paper described the similarity with 
caspase-1 and also reported that CED-3 and caspase-1 
both have similarities to the predicted protein product 
of the murine gene nedd-2, which had been identified on 
the basis of its high level of expression during embryonic 
brain development and its downregulation in the adult 
brain (Kumar et al., 1992). However, the published se- 
quence of the Nedd-2 protein lacked the QACRG casp- 
ase-1 active-site sequence that was present in CED-3 
and that had served as compelling evidence supporting 
the homology between CED-3 and caspase-l. Subse- 
quently, the correct Nedd-2 sequence was determined 
and seen to include the QACRG motif, and nedd-2 was 
demonstrated also to encode a caspase, named casp- 
ase-2 (Wang et al., 1994). All together, a total of 11 
human caspase and 10 murine caspase family members 
have now been identified (Degterev et al., 2003). 
While only a single caspase, CED-3, has been found 
to play a central role in programmed cell death in C. 
elegans (Ellis and Horvitz, 1986; Shaham and Horvitz, 
1996), mammalian apoptosis pathways are executed 
through the concerted actions of multiple caspases ar- 
ranged in protease cascades. The activation of long 
prodomain "initiator" caspases, such as caspase-8 and 
caspase-9, is often not sufficient o cause cell death, 
and their activities must be amplified through the activa- 
tion of downstream "effector" caspases, such as casp- 
ase-3 and caspase-7 (Li et al., 1997; Srinivasula et al., 
1996). Mammalian caspases, especially caspases with 
long prodomains, seem to be highly specialized func- 
tionally and to respond to different apoptotic signals. 
Such specialization is achieved through a combina- 
tion of differential protein-protein interactions and sub- 
cellular Iocalizations. The protein-protein interactions 
are largely mediated via the caspase N-terminal prodo- 
mains, which contain two classes of protein-protein i - 
teraction motifs, known as DED (death effector domain) 
and CARD (caspase activation and recruitment domain) 
domains (Degterev et al., 2003). Caspases with DED 
domains, such as caspase-8, interact with the cyto- 
plasmic domains of the Fas family of death receptors 
indirectly through adaptor proteins that also contain 
DED domains (Muzio et al., 1996) and are responsible 
for initiating apoptosis in response to signals from mem- 
brane receptors. The CARD domain-containing casp- 
ase-9 interacts with a specialized protein complex 
termed the "apoptosome," which includes Apaf-1 (a 
protein that is similar to the worm killer gene product 
CED-4) and cytochrome c and is responsible for mediat- 
ing apoptotic signaling downstream of mitochondria 
(Zou et al., 1999). 
The subcellular localization of caspases also contrib- 
utes to their distinct specificities. Caspase-12 localizes 
to the endoplasmic reticulum (ER) and mediates ER 
stress-induced apoptosis (Nakagawa et al., 2000). Casp- 
ase-2 is at least partially localized to the nucleus and 
mediates DNA damage-induced apoptosis (Lassus et 
al., 2002). The functional specialization of mammalian 
caspases suggests that the amplification of caspases 
in mammalian genomes is at least in part related to the 
complexity of the multiple proapoptotic stimuli encoun- 
tered during the life span of mammals. 
A decade ago, the publication of the Yuan et al. (1993) 
paper helped drive the metamorphosis of apoptosis 
from an obscure field into a mainstream research area. 
The continued study of programmed cell death in C. 
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e/egans has revealed that not only caspases but also 
many other components  of the genetic pathway for pro- 
grammed cell death are conserved between worms and 
mammals  (e.g., see Horvitz, 2003). Recent discoveries 
about programmed cell death in C. elegans--for exam- 
ple, the finding that the process of phagocytosis,  which 
causes cells undergoing programmed cell death to be 
engulfed by neighboring cells, facil itates the death pro- 
cess itself (Reddien et al., 2001)--remain to be explored 
to determine if they apply as well  to mammal ian apopto-  
sis. We anticipate that future f indings about C. e/egans 
programmed cell death--e.g. ,  about how specif ic cells 
decide to live or die or about the physiological ly impor-  
tant targets of the CED-3 caspase- -wi l l  continue to pro- 
pel an understanding of programmed cell death in other 
organisms, including humans. 
The impact of the Yuan et al. (1993) paper and of 
the studies of programmed cell death in C. elegans in 
general provide a powerful demonstrat ion of the value 
of studying the biology of s imple and highly tractable 
experimental  organisms. The prophetic decision by Syd- 
ney Brenner four decades ago to select C. elegans as 
an experimental  organism coupled with the landmark 
achievement by John Sulston of determining the com- 
plete cell l ineage of C. elegans gave us the unique oppor-  
tunity to analyze the mechanisms of programmed cell 
death with single-cell resolution and through the meth- 
ods of analytic genetics and molecular biology. We be- 
lieve that the continued study of C. elegans and of other 
s imple organisms--  including some that may be mostly 
ignored today- -wi l l  continue to drive the understanding 
of fundamental  and universal aspects of biology. We 
also believe that the increasing knowledge of biology 
that derives from such studies, including an increasing 
knowledge of the mechanisms responsible for apopto-  
sis and of the many connections between apoptosis  
and human diseases, will lead to the development of 
new therapeutics that will prove of major benefit to hu- 
mankind. 
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